Reversal of jejunoileal bypass in patients with morbid obesity.

Long-term consequences after jejunoileal bypass for morbid obesity. Dig Dis Sci (1998) 0.97

Reversal of jejunoileal bypass in patients with morbid obesity. Br J Surg (1994) 0.75

Bone disease after jejuno-ileal bypass for obesity. Lancet (1978) 3.84

Failure of chemotherapy to prolong survival in a group of patients with metastatic breast cancer. Lancet (1980) 2.82

Prevention of emesis in patients receiving cytotoxic drugs by GR38032F, a selective 5-HT3 receptor antagonist. Lancet (1987) 2.09

Detection of micrometastases in patients with primary breast cancer. Lancet (1983) 2.07

Impaired hypothalamic control of prolactin secretion in massive obesity. Lancet (1979) 1.95

Assessment of biochemical tests to screen for metastases in patients with breast cancer. Lancet (1980) 1.88

Survey of treatment of primary breast cancer in Great Britain. Br Med J (Clin Res Ed) (1985) 1.80

Vitamin D status and bone histomorphometry in gross obesity. Am J Clin Nutr (1981) 1.79

Assessment of response of bone metastases to systemic treatment in patients with breast cancer. Cancer (1983) 1.73

Diagnosing breast carcinoma in young women. BMJ (1991) 1.71

Effect of antilymphocyte serum on the growth of Hep 2 and HeLa cells in mice. Nature (1968) 1.58

Treatment of gross obesity by jejunal bypass. Br Med J (1974) 1.55

Topical calcipotriol treatment in advanced breast cancer. Lancet (1991) 1.53

Estrogen and progesterone receptors in the normal female breast. Cancer Res (1991) 1.50

Biochemical markers in human breast cancer. Lancet (1977) 1.48

Prediction of endocrine response in breast cancer by immunocytochemical detection of oestrogen receptor in fine-needle aspirates. Lancet (1987) 1.46

Clinical examination, xeromammography, and fine-needle aspiration cytology in diagnosis of breast tumours. Br Med J (1978) 1.44

Physical test for distant metastases in patients with breast cancer. J R Soc Med (1980) 1.42

Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen. Br J Cancer (1981) 1.39

Technique for abdominal radical total gastrectomy. Br J Surg (1989) 1.39

Explanations for weight loss after ileojejunal bypass in gross obesity. Br Med J (1976) 1.37

Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases. Br Med J (Clin Res Ed) (1987) 1.36

Transplantation of primary explants of human tumour to mice treated with antilymphocyte serum. Br J Cancer (1970) 1.36

4-Hydroxyandrostenedione in treatment of postmenopausal patients with advanced breast cancer. Lancet (1984) 1.35

Forearm glucose uptake during the oral glucose tolerance test in normal subjects. Diabetes (1973) 1.34

Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial. Br Med J (Clin Res Ed) (1981) 1.33

Hypomagnesaemia in diabetes. Clin Chim Acta (1979) 1.31

Transplantation of human tumour to immune deprived mice treated with anti-thymocyte serum. Br J Cancer (1973) 1.30

A 13-year review of jejunoileal bypass. Br J Surg (1985) 1.29

Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study. Lancet (1999) 1.28

Aminoglutethimide in treatment of metastatic breast carcinoma. Lancet (1978) 1.27

Growth factor expression in normal, benign, and malignant breast tissue. Br Med J (Clin Res Ed) (1988) 1.24

Bone marrow micrometastases in primary breast cancer: prognostic significance after 6 years' follow-up. Eur J Cancer (1991) 1.23

Receptor mechanisms in the hyperglycaemic response to adrenaline in man. Lancet (1967) 1.22

Human breast-cancer xenografts in immune-suppressed mice. Br J Cancer (1980) 1.20

The intragastric balloon: a novel idea proved ineffective. Br J Surg (1987) 1.20

The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19. Eur J Cancer (1997) 1.18

Chemotherapy of human breast-carcinoma xenografts. Br J Cancer (1980) 1.15

Changing distribution of adenocarcinoma of the stomach. Br J Surg (1987) 1.14

Location of metastatic breast carcinoma by a monoclonal antibody chelate labelled with indium-111. Lancet (1983) 1.12

Practical Diets for Lowering Serum Lipids. Br Med J (1960) 1.11

Malignant myoepithelioma (myoepithelial carcinoma) of the breast: a detailed cytokeratin study. J Clin Pathol (1995) 1.09

Abnormal sex steroid secretion and binding in massively obese women. Clin Endocrinol (Oxf) (1980) 1.09

Growth of 2 human tumour cell lines in mice treated with antilymphocyte serum. Nature (1967) 1.08

Effect of sympathomimetic compounds with beta-adrenergic effects on plasma free fatty acids in man. J Lipid Res (1966) 1.06

The surgical significance of the ileo-caecal junction. Ann R Coll Surg Engl (1968) 1.05

Oestrogen receptor content of normal breast cells and breast carcinomas throughout the menstrual cycle. Br Med J (Clin Res Ed) (1988) 1.04

Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report. Cancer Res (1986) 1.04

Diet and Plasma Cholesterol in 99 Bank Men. Br Med J (1963) 1.03

Combination chemotherapy for thrombocytopenia with bone marrow metastases from breast cancer. Br Med J (1977) 1.03

Carcinoma of the exocrine pancreas. Clin Oncol (1984) 1.03

A semiautomated fluorimetric method for the enzymatic determination of pyruvate, lactate, acetoacetate, and beta-hydroxybutyrate levels in plasma. J Lab Clin Med (1966) 1.02

Treatment of advanced breast cancer in postmenopausal women with 4-hydroxyandrostenedione. Cancer Chemother Pharmacol (1990) 1.00

Inhibitors of fibrin cross-linking: relevance for thrombolysis. Nature (1966) 0.99

Evidence for existence of two types of massive obesity. Br Med J (1980) 0.99

Presurgical determination of estrogen receptor status using immunocytochemically stained fine needle aspirate smears in patients with breast cancer. Cancer Res (1987) 0.99

A biochemical approach to the staging of human breast cancer. Cancer (1977) 0.98

The prevalence of haemorrhoids. A preliminary survey. Proc R Soc Med (1970) 0.97

An assessment of the effects of hormones on short term organ cultures of human breast carcinomata. Br J Cancer (1975) 0.96

Lactic acidosis. A presentation of metastatic breast cancer arising in pregnancy. Cancer (1992) 0.95

The fate of bone marrow micrometastases in patients with primary breast cancer. J Clin Oncol (1989) 0.95

Preliminary study of the treatment of advanced breast cancer in postmenopausal women with the aromatase inhibitor CGS 16949A. Cancer Res (1990) 0.95

The immunohistochemical demonstration of lipoproteins in vessel walls. J Pathol Bacteriol (1965) 0.93

Analgesic benefit of locally injected bupivacaine after hemorrhoidectomy. Dis Colon Rectum (1990) 0.92

Postchemotherapy staging laparotomy in Hodgkin's disease. Br J Cancer (1982) 0.92

Effect of long term tamoxifen treatment on bone turnover in women with breast cancer. BMJ (1993) 0.92

Detection of breast carcinoma metastases in bone: relative merits of X-rays and skeletal scintigraphy. Lancet (1983) 0.92

Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma. Cancer Res (1982) 0.91

Danazol treatment of advanced breast cancer. Cancer Treat Rep (1981) 0.91

Low-dose aminoglutethimide in treatment of advanced breast cancer. Lancet (1984) 0.91

The importance of the resection margin in conservative surgery for breast cancer. Eur J Surg Oncol (1996) 0.90

Persistence of defective hypothalamic control of prolactin secretion in some obese women after weight reduction. Br Med J (1980) 0.90

Failure of methyl-C.C.N.U. and 5-fluorouracil in colorectal cancer. Lancet (1978) 0.90

Comparative functional histopathology of human breast carcinoma xenografts. Br J Cancer (1981) 0.88

Tests for liver metastases in breast cancer: evaluation of liver scan and liver ultrasound. Clin Oncol (1980) 0.88

Liver biopsy at lymphoma laparotomy. Lancet (1978) 0.88

Oral contraceptives and survival in breast cancer. Br J Cancer (1987) 0.88

A method fo lipoprotein electrophoresis using agarose gel. Clin Chim Acta (1968) 0.88

Where will this month's medical school intake go? Lancet (1986) 0.87

Combination treatment with tamoxifen and aminoglutethimide in advanced breast cancer. Br Med J (Clin Res Ed) (1983) 0.87

Tissue magnesium status in diabetes mellitus. Diabetologia (1981) 0.87

Bilateral carcinoma of the breast. Eur J Surg Oncol (1993) 0.86

Absorption of vitamin B-12 from the small intestine. Study in man, monkey, cat, and dog. Br J Surg (1967) 0.86

The effect of weight loss on sex steroid secretion and binding in massively obese women. Clin Endocrinol (Oxf) (1981) 0.86

The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer. Br J Cancer (1990) 0.85

Studies in vivo of the ileocaeco-colic sphincter in the cat and dog. Gut (1966) 0.85

The changing role of staging laparotomy in Hodgkin's disease: a personal series of 310 patients. Br J Surg (1982) 0.85

15-keto-13,14-dihydroprostaglandin E2 concentrations in serum of patients with breast cancer. Lancet (1977) 0.85

Hodgkin's disease in children. Br J Cancer (1977) 0.85

Diurnal profiles of plasma magnesium and blood glucose in diabetes. Diabetologia (1982) 0.84

The importance of the non-palpable lesion in women under 50, detected by mammography on self-referral for screening, symptoms or follow up. Eur J Surg Oncol (1995) 0.84

Effect of intrinsic factor on absorption of vitamin B12 from small intestine. Lancet (1967) 0.84

Use of silicone implants after wide local excision of the breast. Br J Surg (1993) 0.84

Screening for metastases in breast cancer: an assessment of biochemical and physical methods. Cancer (1981) 0.84